Recurrent Adult Soft Tissue Sarcoma Completed Phase 1 / 2 Trials for Vismodegib (DB08828)

IndicationStatusPhase
DBCOND0028931 (Recurrent Adult Soft Tissue Sarcoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01154452Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaTreatment